MRSA Notes

MRSA Notes header image 2

High Rate of Methicillin-resistant Staphylococcus Infection Seen in Dalbavancin Phase 3 Trials: Presented at IDSA

October 12th, 2005 · No Comments

“SAN FRANCISCO, CA — October 11, 2005 — Methicillin-resistance occurred in almost half of all patients with Staphylococcus aureus who were treated for skin and skin structure infections in Phase 3 studies of a new antibiotic aimed at controlling resistant bacteria.”

News - High Rate of Methicillin-resistant Staphylococcus Infection Seen in Dalbavancin Phase 3 Trials: Presented at IDSA

Tags: MRSA Drugs

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

Leave a Comment

Close
E-mail It